Alembic Pharmaceuticals Limited Overview
Pro stress-test →Alembic Pharmaceuticals is an Indian multinational pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of pharmaceutical products across multiple therapeutic areas. The company operates through both branded and generic formulations, serving domestic and international markets with a significant presence in India, USA, and other emerging markets.
Strategic Profile
Pro stress-test →Alembic competes in the highly competitive generic and branded pharmaceutical space, with strategic advantages in cost-effective manufacturing and established distribution networks in India. The company focuses on high-value therapeutic segments including cardiovascular, anti-diabetic, and gastrointestinal products to differentiate from competitors.
Competitive Landscape
Pro stress-test →Alembic competes with larger Indian pharma companies like Cipla, Aurobindo Pharma, and Cadila Healthcare, as well as international generic manufacturers. The competitive advantage lies in manufacturing efficiency and domestic distribution, though the company faces pricing pressure from competitors with stronger international presence.
Industry Context
Alembic Pharmaceuticals Limited operates in Pharmaceuticals - Generics and Branded Formulations.
Key facts
Founded: 1907 · Headquarters: Vadodara, India · Employees: 2,500+ · Revenue: $250-300M · Market cap: N/A